05 Nov 2019 by admin in UncategorizedComments Syros to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019
05 Nov 2019 by admin in UncategorizedComments resTORbio Reports Third Quarter 2019 Financial Results and Corporate Update
04 Nov 2019 by admin in UncategorizedComments NextCure to Host and Webcast Event at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
25 Oct 2019 by admin in UncategorizedComments New Biotechnology publication validates Crescendo Biologics’ platform as it moves towards the clinic
17 Oct 2019 by admin in UncategorizedComments Syros Announces Update on Selective CDK7 Inhibitor Portfolio
07 Oct 2019 by admin in UncategorizedComments Tempest Therapeutics Names Biopharmaceutical Executive Stephen Brady as President and Chief Operating Office
03 Oct 2019 by admin in UncategorizedComments Arcellx Raises $85 Million in a Series B Financing to Advance its Intelligent Cell Therapy Platform
02 Oct 2019 by admin in UncategorizedComments NextCure Announces Promotion of Timothy Mayer, Ph.D., to Chief Operating Officer
24 Sep 2019 by admin in UncategorizedComments Crescendo Biologics Reaches Fifth Milestone in its Strategic Collaboration with Takeda
12 Sep 2019 by admin in UncategorizedComments Crescendo Biologics to collaborate with world-leading oncology groups at the University of Oxford and the University of Surrey
